Pingping Hou
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 21, 2024
NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer.Daiyong Deng, Habeebunnisa Begum, Tong Liu
|Dec 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.Pat Gulhati, Aislyn Schalck, Shan Jiang
|Oct 14, 2022
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance.Daiyong Deng, Riya Patel, Cheng-Yao Chiang
|Sep 17, 2021
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer.Pingping Hou, Xingdi Ma, Zecheng Yang
|Sep 22, 2020
Telomere dysfunction activates YAP1 to drive tissue inflammation.Deepavali Chakravarti, Baoli Hu, Xizeng Mao
|Apr 29, 2020
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer.Pingping Hou, Avnish Kapoor, Qiang Zhang
Pageof 1
Frequent Collaborators
3 joint publications
Ronald A DePinho
2 joint publications
Chang-Jiun Wu
2 joint publications
Denise J Spring
1 joint publications
Ming Tang
1 joint publications
Xingdi Ma
1 joint publications
Jeffrey J Ackroyd
1 joint publications
Jiexi Li
1 joint publications
Wen-Ting Liao
1 joint publications
Prasenjit Dey
1 joint publications
Kyle A LaBella
